Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Univest Financial
UVSP
$1.18B
| $12.9M | 0.02% |
497,569
+85,480
| +21% | +$2.4M |
|
|
PPLI
1077
People Inc
PPLI
$3.02B
| $12.9M | 0.02% |
977,669
+721,959
| +282% | +$9.39M |
|
|
CTWS
1078
DELISTED
Connecticut Water Service Inc
CTWS
| $12.9M | 0.02% |
242,200
+4,100
| +2% | +$222K |
|
1079
KKR & Co
KKR
$99.5B
| $12.9M | 0.02% |
705,650
-2,098,300
| -75% | -$37.3M |
|
|
SNR
1080
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $12.9M | 0.02% |
1,260,700
+235,700
| +23% | +$2.39M |
|
|
AEGN
1081
DELISTED
Aegion Corp
AEGN
| $12.8M | 0.02% |
560,096
+34,596
| +7% | +$796K |
|
|
ASCMA
1082
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $12.8M | 0.02% |
903,200
+9,800
| +1% | +$155K |
|
|
LQ
1083
DELISTED
La Quinta Holdings Inc.
LQ
| $12.7M | 0.02% |
942,000
-65,192
| -6% | -$911K |
|
|
TVTY
1084
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $12.7M | 0.02% |
436,889
-738,300
| -63% | -$19.5M |
|
1085
Booz Allen Hamilton
BAH
$9.43B
| $12.7M | 0.02% |
358,494
-315,500
| -47% | -$11.3M |
|
|
SWIR
1086
DELISTED
Sierra Wireless
SWIR
| $12.7M | 0.02% |
477,183
+207,499
| +77% | +$4.78M |
|
1087
QCR Holdings
QCRH
$1.73B
| $12.7M | 0.02% |
299,000
+55,100
| +23% | +$2.36M |
|
1088
Kilroy Realty
KRC
$4.22B
| $12.7M | 0.02% |
175,600
-318,100
| -64% | -$23.5M |
|
1089
Cohu
COHU
$2.66B
| $12.6M | 0.02% |
684,459
+76,405
| +13% | +$1.16M |
|
|
P
1090
Everpure Inc
P
$37B
| $12.6M | 0.02% |
1,284,000
+1,062,700
| +480% | +$11.8M |
|
1091
Ionis Pharmaceuticals
IONS
$9.39B
| $12.6M | 0.02% |
313,214
-136,300
| -30% | -$6.12M |
|
1092
Essential Utilities
WTRG
$11.3B
| $12.6M | 0.02% |
391,617
-463,000
| -54% | -$14.2M |
|
|
NYRT
1093
DELISTED
New York REIT, Inc.
NYRT
| $12.6M | 0.02% |
+129,590
| New | +$12.7M |
|
|
UTEK
1094
DELISTED
Ultratech Inc.
UTEK
| $12.5M | 0.02% |
422,356
+335,000
| +383% | +$9.29M |
|
1095
Lincoln National
LNC
$8.44B
| $12.5M | 0.02% |
+190,674
| New | +$13M |
|
|
TAST
1096
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $12.4M | 0.02% |
879,300
-27,200
| -3% | -$406K |
|
1097
Merit Medical Systems
MMSI
$5.45B
| $12.4M | 0.02% |
430,352
+128,952
| +43% | +$3.61M |
|
|
ARR
1098
Armour Residential REIT
ARR
$2.36B
| $12.4M | 0.02% |
109,464
+75,408
| +221% | +$8.28M |
|
1099
Cincinnati Financial
CINF
$26.5B
| $12.4M | 0.02% |
171,945
-48,455
| -22% | -$3.51M |
|
|
CHMI
1100
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $12.4M | 0.02% |
724,400
+136,400
| +23% | +$2.48M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.